Global Point of Care

Afinion™ HbA1c Dx

Diagnosis in Minutes.

Introducing the first-ever HbA1c test cleared for diagnosis at the POC.

Finally — an HbA1c test that can be used as an aid to diagnose and monitor your patients with diabetes or pre-diabetes at the point of care in just 3 minutes.

Diagnosing patients with diabetes just got a lot easier with the Afinion™ HbA1c Dx for use on the Afinion Analyzer. 

  1. Diabetes C, Complications Trial Research G, Nathan DM, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
  2. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.
  3. Swensen MH, et al. Evaluation of the Alere Afinion HbA1c Dx Test: Can Point of Care HbA1c Testing Deliver the Performance Needed for Diagnostic Use? American Diabetes Association’s 76th Scientific Sessions; June 10-14, 2016; New Orleans, LA.
  4. Rio Grande case study:
  5. Patzer KH et. al. J Diab Sci Technol. 2018 May;12(3):687-694 study